XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Feb. 28, 2022
Feb. 28, 2021
Operating Activities:    
Net income $ 61,991 $ 56,144
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 32,701 31,765
Allowance for doubtful accounts 12 31
Loss on sale of property and equipment 724 202
Deferred income taxes (2,124) (1,997)
Equity in losses of unconsolidated affiliates 24 21
Stock-based compensation 8,674 8,290
Change in operating assets and liabilities:    
Receivables, prepaid expenses and other current assets, non-current assets, accrued salaries and benefits, deferred membership income and other accruals (19,503) 10,156
Merchandise inventories (80,608) (29,728)
Accounts payable (9,811) (45,157)
Net cash provided by (used in) operating activities (7,920) 29,727
Investing Activities:    
Proceeds from the disposal of Aeropost, net of divested cash 4,959  
Additions to property and equipment (60,468) (47,170)
Purchases of short-term investments (17,658) (51,314)
Proceeds from settlements of short-term investments 41,075 16,158
Purchases of long-term investments   (1,477)
Proceeds from settlements of long-term investments 1,484 1,477
Proceeds from disposal of property and equipment 77 50
Net cash used in investing activities (30,531) (82,276)
Financing Activities:    
Proceeds from long-term bank borrowings 30,180 3,000
Repayment of long-term bank borrowings (10,969) (8,467)
Proceeds from short-term bank borrowings 20,179  
Repayment of short-term bank borrowings (4,488) (41,916)
Cash dividend payments (13,275) (11,021)
Purchase of treasury stock (3,784) (2,239)
Other financing activities   (171)
Net cash provided by (used in) financing activities 17,843 (60,814)
Effect of exchange rate changes on cash and cash equivalents and restricted cash 42 (2,629)
Net decrease in cash, cash equivalents (20,566) (115,992)
Cash, cash equivalents and restricted cash at beginning of period 215,479 303,771
Cash, cash equivalents and restricted cash at end of period 194,913 187,779
Supplemental disclosure of noncash investing activities:    
Capital expenditures accrued, but not yet paid 8,369 11,529
Reconciliation of cash, cash equivalents, and restricted cash:    
Cash and cash equivalents 178,705 180,179
Short-term restricted cash 4,172 736
Long-term restricted cash 12,036 6,864
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows $ 194,913 $ 187,779